Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,269 | 0 | N/A | 0 | 0 |
| Marketable Securities | 225,975 | 0 | N/A | 0 | 0 |
| TOTAL | $340,666 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,474 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,958 | 0 | 0 | 0 | 0 |
| TOTAL | $5,432 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $346,098 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,875 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 5,517 | 0 | N/A | 0 | 0 |
| TOTAL | $8,095 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,117 | 0 | 0 | 0 | 0 |
| TOTAL | $1,117 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,212 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,576 | N/A | N/A | N/A | N/A |
| Common Shares | 36 | 0 | N/A | 0 | 0 |
| Retained earnings | -86,228 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | -183 | 0 | 0 | 0 | 0 |
| TOTAL | $336,886 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $346,098 | $0 | $0 | $0 | $0 |